AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,977,860 | -72.0% | 386,200 | -55.1% | 0.00% | -50.0% |
| Q2 2023 | $14,183,891 | +84.8% | 860,673 | +2.7% | 0.00% | 0.0% |
| Q1 2023 | $7,675,860 | +17.8% | 837,976 | -7.9% | 0.00% | 0.0% |
| Q4 2022 | $6,514,956 | +49.8% | 909,910 | +4.8% | 0.00% | – |
| Q3 2022 | $4,349,000 | +73.1% | 867,969 | -15.7% | 0.00% | – |
| Q2 2022 | $2,512,000 | -41.4% | 1,029,300 | +63.9% | 0.00% | – |
| Q1 2022 | $4,288,000 | -46.5% | 627,871 | -36.7% | 0.00% | – |
| Q4 2021 | $8,010,000 | -6.7% | 991,316 | +13.2% | 0.00% | -100.0% |
| Q3 2021 | $8,584,000 | +96.7% | 876,014 | +35.1% | 0.00% | – |
| Q2 2021 | $4,364,000 | +32.2% | 648,312 | +77.4% | 0.00% | – |
| Q1 2021 | $3,302,000 | -17.5% | 365,376 | -39.0% | 0.00% | – |
| Q4 2020 | $4,002,000 | +143.6% | 599,222 | +83.8% | 0.00% | – |
| Q3 2020 | $1,643,000 | -12.7% | 325,937 | +39.8% | 0.00% | – |
| Q2 2020 | $1,883,000 | -47.6% | 233,100 | -48.5% | 0.00% | -100.0% |
| Q1 2020 | $3,595,000 | -11.0% | 452,700 | -15.4% | 0.00% | 0.0% |
| Q4 2019 | $4,039,000 | +324.7% | 535,014 | +134.1% | 0.00% | – |
| Q3 2019 | $951,000 | +11.9% | 228,539 | -22.3% | 0.00% | – |
| Q2 2019 | $850,000 | +2079.5% | 294,267 | +987.4% | 0.00% | – |
| Q1 2019 | $39,000 | -72.1% | 27,061 | -50.1% | 0.00% | – |
| Q4 2018 | $140,000 | -66.8% | 54,182 | -43.6% | 0.00% | – |
| Q3 2018 | $422,000 | -46.6% | 96,089 | -25.4% | 0.00% | – |
| Q2 2018 | $790,000 | -25.0% | 128,815 | -10.9% | 0.00% | – |
| Q1 2018 | $1,054,000 | +95.9% | 144,573 | +120.5% | 0.00% | – |
| Q4 2017 | $538,000 | +95.6% | 65,580 | +151.1% | 0.00% | – |
| Q3 2017 | $275,000 | +109.9% | 26,122 | +93.5% | 0.00% | – |
| Q1 2017 | $131,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |